Elevated levels of soluble CD14 in serum of patients with acute Plasmodium falciparum malaria

Clinical and Experimental Immunology

Volumn 105, Issue 1, 1996, Pages 74-78

  Wenisch, C ^a   Wenisch, H ^a   Parschalk, B ^a   Vanijanonta, S ^b   Burgmann, H ^a   Exner, M ^a   Zedwitz Liebenstein, K ^a   Thalhammer, F ^a   Georgopoulos, A ^a   Graninger, W ^a   Looareesuwan, S ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Plasmodium falciparum malaria; septicaemia; soluble CD14; tumour necrosis factor

Indexed keywords

ARTESUNATE; CD14 ANTIGEN; CREATININE; ENDOTOXIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD CULTURE; BLOOD LEVEL; BLOOD SMEAR; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FAILURE; MALARIA; MALE; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SEPTICEMIA; SERUM;

EID: 8944252795     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.d01-723.x     Document Type: Article

References (39)

1. Simmons DL, Tan S, Tenen DG, Nicolson-Weller A, Seed B. Monocyte antigen CD14 is a phospholipid anchored membrane protein. Blood 1989; 73:284-9.
2. Weingarten R, Sklar LA, Mathison JC et al. Interactions of lipopolysaccharide with neutrophils in blood via CD14. J Leukocyte Biol 1993; 53:18-24.
3. Bazil U, Straninger SL. Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes. J Immunol 1991; 147:1567-74.
4. Krüger C, Schütt C, Obertacke O et al. Serum CD14 levels in polytraumatized and severely burned patients. Clin Exp Immunol 1991; 85:297-301.
5. Dozil V, Horejes V, Bandys M, Kristofova H, Strominger JL, Losta W, Hilgert I. Biochemical characterization of a soluble form of the 53 kDa monocyte surface antigen. Eur J Immunol 1986; 16:1583-9.
6. Bozil V, Bondys M, Hilgert I et al. Structural relationship between the soluble and membrane-bound forms of human monocyte surface glycoprotein CD14. Mol Immunol 1989; 26:657-62.
7. Schütt C, Schilling T, Grunwald V, Schönfeld W, Krüger C. Endotoxin-neutralizing capacity of soluble CD14. Res Immunol 1992; 143:1-8.
8. Frey EA, Miller DS, Jahr TG et al. Soluble CD 14 participates in the response of cells to lipopolysaccharide. J Exp Med 1992; 176:1665-71.
9. Kwiatkowski D, Hill AVS, Sambon I et al. TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet 1990; 336:1201-4.
10. Clark IA, Rockett KA, Lowalen WB. Proposed link between cytokines, nitric oxide and human cerebral malaria. Parasitol Today 1991; 7:205-7.
11. Usawattanakul W, Tharavanij S, Warrel DA, Looareesuwan S, White NJ, Supavej S, Soikratoke S. Factors contributing to the development of cerebral malaria: endotoxin. Clin Exp Immunol 1985; 61:562-8.
12. Guideline on validation of the Limulus Amebocyte Lysate test as an end-product endotoxin test for human and animal parenteral drugs, biological products and medical devices. US Department of Health and Human Services, Food and Drug Administration, July 15, 1991.
13. Wenisch C, Parschalk B, Narzt E, Looareesuwan S, Graninger W. Elevated serum levels of IL-10 and IFN-gamma in patients with acute Plasmodium falciparum malaria. Clin Immunol Immunopathol 1995; 74:115-7.
14. Graninger W, Thalhammer F, Locker G. Pentoxifylline in cerebral malaria. J Infect Dis 1991; 164:829.
15. Landmann R, Zimmerli, Sansano S, Link S, Hahn A, Glauser MP, Calandra T. Increased circulating soluble CD14 is associated with high mortality in Gram-negative septic shock. J Infect Dis 1995; 171:639-44.
16. Labeta MO, Durieux JJ, Fernandex N, Herrmann R, Ferrara P. Release from a human monocyte-like cell line of two different soluble forms of the lipopolysaccharide receptor CD14. Eur J Immunol 1993; 23:2144-51.
17. Haziot A, Tsuberi BZ, Goyert SM. Neutrophil CD14: biochemical properties and role in the secretion of tumor necrosis factor-alpha in response to lipopolysaccharide. J Immunol 1993; 150:5556-65.
18. Landmann R, Fisscher AE, Obrecht JP. Interferon-gamma and interleukin-4 downregulate soluble CD14 release in human monocytes and macrophages. J Leukoc Biol 1992;52:323-30.
19. Haziot A, Chen S, Ferrero E, Low GM, Silber R, Goyert SM. The monocyte differentiation antigen CD14 is anchored to the cell membrane by a phosphatidylinositol linkage. J Immunol 1988; 141:547-52.
20. Felton SC, Prior RB, Spagna VA, Kreier JP. Evaluation of Plasmodium berghei for endotoxin by the limulus lysatc assay. J Parasitol 1980; 66:846-8.
21. Greenwood BM, Evans Jones LG, Stratton D. Failure to detect endotoxin in serum of children with malaria. Lancet 1975; ii:874-5.
22. Glew RH, Levin J. Failure to demonstrate circulating endotoxin in malaria. Proc Soc Exp Biol Med 1975; 148:508-10.
23. Prada J, Alabi SA, Bienzle U. Bacterial strains isolated from blood cultures of Nigerian children with cerebral malaria. Lancet 1993; 342:1114.
24. Akpede GO, Abiodun PO, Sykes RM. Occult bacteraemia in a malarious area: presenting features and antimicrobial susceptibility. J Trop Pediatr 1993; 39:377-8.
25. Prada J, Prager C, Neifer S, Bienzle U, Kremsner PG. Production of interleukin-6 by human and murine mononuclear leukocytes stimulated with Plasmodium antigens is enhanced by pentoxifylline and tumor necrosis factor secretion is reduced. Infect Immun 1993; 61:2737-40.
26. Di Perri G, Di Perri IG, Monteiro GB et al. Pentoxifylline as a supportive agent in the treatment of cerebral malaria in children. J Infect Dis 1995; 171:1317-22.
27. Clark IA. Does endotoxin cause both the disease and parasite death in acute malaria and babesiosis? Lancet 1978; ii:75-77.
28. Alving CR, Richards RL. Liposomes containing lipid A: a potent nontoxic adjuvant for a human malaria sporozoite vaccine. Immunol Letters 1990; 25:275-9.
29. Loose LD, Trejo R, Di-Luzio NR. Impaired endotoxin detoxification as a factor in enhanced endotoxin sensitivity of malaria infected mice. Proc Soc Exp Biol Med 1971; 137:794-7.
30. Pugin J, Schürer-Maly LL, Ceturea D, Moviarty A, Ulevitch RS, Tobias PS. Lipopolysaeeharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide binding protein and soluble CD14. Proc Natl Acad Sci USA 1993; 90:2744-8.
31. Thorp KM, Southern C, Bird IN, Matthews N. Tumour necrosis factor induction of ELAM-1 and ICAM-1 on human umbilical vein endothelial cells - an analysis of tumour necrosis factor-receptor interactions. Cytokine 1992; 4:313-9.
32. Ockenhouse CF, Ho M, Tandon NN et al. Molecular basis of sequestration in severe and uncomplicated Plasmodium falciparum malaria: differential adhesion of infected erythrocytes to CD36 and ICAM-1. J Infect Dis 1991; 164:163-9.
33. Berendt AR, Simmons DI, Tanscy J, Newbold CI, Marsh K. Intercellular adhesion molecule is an endothelial cell adhesion receptor for Plasmodium fulciparum. Nature 1989; 341:57.
34. Ockenhouse CF, Tegochi T, Maeno Y et al. Human vasulcar cell adhesion receptors for Plasmodium falciparum-infected erythrocytes: roles for endothelial leukocyte adhesion molecule 1 and vascular cell adhesion molecule 1. J Exp Med 1992; 176:1183-9.
35. Howard RJ, Gilladoga AD. Molecular studies related to the pathogenesis of cerebral malaria. Blood 1989; 74:2603-9.
36. Haziot A, Tsuberi BZ, Goyert SM. Neutrophil CD14: biochemical properties and role in the secretion of tumor necrosis factor-alpha in response to lipopolysaccharide. J Immunol 1993; 12:5556-65.
37. Yasui K, Komiyama A, Molski TFP, Sha'afi RI. Pentoxifylline and CD14 antibody antibody inhibit priming of polymorphonuclear leukocytes for enhanced release of superoxide by lipopolysaccharide: possible mechanism of action. Infect Immun 1994; 62:922-7.
38. Han J, Thompson B, Bentler B. Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis of separate points in the signalling pathway. J Exp Med 1990; 172:391-4.
39. Yasni K, Komiyama A, Molski TFP, Sha'afi RI. Pentoxifylline and CD14 antibody additively inhibit priming of polymorphonuclear leukocyte for enhanced release of superoxide by lipopolysaccharide: possible mechanism of these actions. Infect Immunol 1994; 62:922-7.